• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体甘露聚糖结合凝集素激活途径起始复合物的两种成分由单个结构基因编码。

Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene.

作者信息

Stover C M, Thiel S, Thelen M, Lynch N J, Vorup-Jensen T, Jensenius J C, Schwaeble W J

机构信息

Department of Microbiology and Immunology, University of Leicester, United Kingdom.

出版信息

J Immunol. 1999 Mar 15;162(6):3481-90.

PMID:10092804
Abstract

Mannan-binding lectin (MBL) forms a multimolecular complex with at least two MBL-associated serine proteases, MASP-1 and MASP-2. This complex initiates the MBL pathway of complement activation by binding to carbohydrate structures present on bacteria, yeast, and viruses. MASP-1 and MASP-2 are composed of modular structural motifs similar to those of the C1q-associated serine proteases C1r and C1s. Another protein of 19 kDa with the same N-terminal sequence as the 76-kDa MASP-2 protein is consistently detected as part of the MBL/MASP complex. In this study, we present the primary structure of this novel MBL-associated plasma protein of 19 kDa, MAp19, and demonstrate that MAp19 and MASP-2 are encoded by two different mRNA species generated by alternative splicing/polyadenylation from one structural gene.

摘要

甘露聚糖结合凝集素(MBL)与至少两种MBL相关丝氨酸蛋白酶MASP-1和MASP-2形成多分子复合物。该复合物通过与细菌、酵母和病毒上存在的碳水化合物结构结合,启动补体激活的MBL途径。MASP-1和MASP-2由与C1q相关丝氨酸蛋白酶C1r和C1s相似的模块化结构基序组成。始终检测到一种19 kDa的蛋白质,其N端序列与76 kDa的MASP-2蛋白相同,作为MBL/MASP复合物的一部分。在本研究中,我们展示了这种新型19 kDa的MBL相关血浆蛋白MAp19的一级结构,并证明MAp19和MASP-2由一个结构基因通过可变剪接/聚腺苷酸化产生的两种不同mRNA编码。

相似文献

1
Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene.补体甘露聚糖结合凝集素激活途径起始复合物的两种成分由单个结构基因编码。
J Immunol. 1999 Mar 15;162(6):3481-90.
2
The rat and mouse homologues of MASP-2 and MAp19, components of the lectin activation pathway of complement.补体凝集素激活途径的组成成分MASP-2和MAp19的大鼠和小鼠同源物。
J Immunol. 1999 Dec 15;163(12):6848-59.
3
Murine serine proteases MASP-1 and MASP-3, components of the lectin pathway activation complex of complement, are encoded by a single structural gene.小鼠丝氨酸蛋白酶MASP-1和MASP-3是补体凝集素途径激活复合物的组成成分,由一个结构基因编码。
Genes Immun. 2003 Jul;4(5):374-84. doi: 10.1038/sj.gene.6363970.
4
A second serine protease associated with mannan-binding lectin that activates complement.第二种与甘露聚糖结合凝集素相关的丝氨酸蛋白酶,可激活补体。
Nature. 1997 Apr 3;386(6624):506-10. doi: 10.1038/386506a0.
5
The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of the lectin route of complement activation, is part of a tightly linked gene cluster on chromosome 1p36.2-3.人甘露聚糖结合凝集素相关丝氨酸蛋白酶-2(MASP-2)基因是补体激活凝集素途径的效应成分,位于1号染色体1p36.2-3上紧密连锁的基因簇中。
Genes Immun. 2001 May;2(3):119-27. doi: 10.1038/sj.gene.6363745.
6
Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19.C1q和甘露糖结合凝集素(MBL)与C1r、C1s、MBL相关丝氨酸蛋白酶1和2以及MBL相关蛋白MAp19的相互作用。
J Immunol. 2000 Jul 15;165(2):878-87. doi: 10.4049/jimmunol.165.2.878.
7
The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes.甘露聚糖结合凝集素相关丝氨酸蛋白酶(MASPs)和MAp19:由两个基因编码的凝集素途径激活复合物的四个组分。
Immunobiology. 2002 Sep;205(4-5):455-66. doi: 10.1078/0171-2985-00146.
8
MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway.MASP-2,即甘露聚糖结合凝集素补体激活途径中产生C3转化酶的蛋白酶。
Immunobiology. 1998 Aug;199(2):348-57. doi: 10.1016/S0171-2985(98)80039-9.
9
Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL.人甘露聚糖结合凝集素(MBL)相关丝氨酸蛋白酶-1和-2、MBL相关蛋白19以及MBL的相互作用特性
J Immunol. 2001 Apr 15;166(8):5068-77. doi: 10.4049/jimmunol.166.8.5068.
10
Collectins and collectin receptors in innate immunity.天然免疫中的凝集素和凝集素受体
APMIS Suppl. 2000;100:1-59.

引用本文的文献

1
The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems.补体系统凝集素途径的激活、调控、疾病关联及与其他(蛋白水解)系统的相互作用。
Int J Mol Sci. 2024 Jan 26;25(3):1566. doi: 10.3390/ijms25031566.
2
MASP3 Deficiency in Mice Reduces but Does Not Abrogate Alternative Pathway Complement Activity Due to Intrinsic Profactor D Activity.MASP3 缺陷小鼠的替代途径补体活性降低但并未完全消除,这是由于固有类因子 D 活性的存在。
J Immunol. 2023 May 15;210(10):1543-1551. doi: 10.4049/jimmunol.2200932.
3
Tinker, tailor, soldier, cell: the role of C-type lectins in the defense and promotion of disease.
修补匠、裁缝、士兵、细胞:C 型凝集素在疾病防御和促进中的作用。
Protein Cell. 2022 Jul 15;14(1):4-16. doi: 10.1093/procel/pwac012. eCollection 2023 Jan.
4
MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19.甘露聚糖结合凝集素相关丝氨酸蛋白酶处于补体和凝血级联反应的交叉点——以新冠肺炎为例
Genet Mol Biol. 2021 Mar 17;44(1 Suppl 1):e20200199. doi: 10.1590/1678-4685-GMB-2020-0199. eCollection 2021.
5
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.补体系统的治疗靶向:从罕见病到流行病。
Pharmacol Rev. 2021 Apr;73(2):792-827. doi: 10.1124/pharmrev.120.000072.
6
The ambiguous role of mannose-binding lectin (MBL) in human immunity.甘露糖结合凝集素(MBL)在人体免疫中的模糊作用。
Open Med (Wars). 2021 Feb 17;16(1):299-310. doi: 10.1515/med-2021-0239. eCollection 2021.
7
Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target.子宫内膜异位症的免疫学基础:补体系统作为潜在的治疗靶点。
Front Immunol. 2021 Jan 11;11:599117. doi: 10.3389/fimmu.2020.599117. eCollection 2020.
8
Key Components of the Complement Lectin Pathway Are Not Only Required for the Development of Inflammatory Arthritis but Also Regulate the Transcription of Factor D.补体凝集素途径的关键成分不仅是炎症性关节炎发展所必需的,而且还调节因子 D 的转录。
Front Immunol. 2020 Feb 21;11:201. doi: 10.3389/fimmu.2020.00201. eCollection 2020.
9
Circulating lectin pathway proteins do not predict short-term cardiac outcomes after myocardial infarction.循环凝集素通路蛋白不能预测心肌梗死后的短期心脏结局。
Clin Exp Immunol. 2019 Oct;198(1):94-100. doi: 10.1111/cei.13315. Epub 2019 Jun 3.
10
Factors involved in initiation and regulation of complement lectin pathway influence postoperative outcome after pediatric cardiac surgery involving cardiopulmonary bypass.补体凝集素途径的启动和调节所涉及的因素影响体外循环小儿心脏手术后的术后结果。
Sci Rep. 2019 Feb 27;9(1):2930. doi: 10.1038/s41598-019-39742-w.